Grünenthal Limited
TOR Building
St Cloud Way
Maidenhead SL6 8BN
Phone: +44 (0)870 351 8960

For Medical Information, Reporting Safety and Quality Related Issues see here

... About us

We are an independent, family-owned company with headquarters in Aachen, Germany. We are present in 29 countries with affiliates in Europe, Latin America and the USA. Our products are sold in more than 100 countries and we employ around 4,700 employees worldwide.

... Company Overview

Although firmly rooted in Germany, today we are very much a growing global business.

... History

At Grünenthal, conducting our business responsibly is a core part of our company’s strategy and culture. As a global leader in pain management, Grünenthal aspires to create a positive impact on society – in our core business and beyond. We are guided by integrity, transparency and the highest ethical standards.

... Responsibility

Although firmly rooted in Germany, today we’re very much a growing global business, represented in 27 countries and maintaining production sites in five.

... Global Capabilities

We are dedicated to creating a better future for our patients, so getting involved with diverse initiatives that support this goal is vital.

... Initiatives

... Requests for Funding

Patients’ needs are at the heart of everything we do; using our passion for science, we develop long-lasting solutions that directly address these needs.

... Products

We are dedicated to creating a better future for our patients, read the package leaflet information to find out more about Ationdo.

... Ationdo

We are dedicated to creating a better future for our patients, read the package leaflet information to find out more about Nebido.

... Nebido

We are dedicated to creating a better future for our patients, read the package leaflet information to find out more about Palexia.

... Palexia

We are dedicated to creating a better future for our patients, read the package leaflet information to find out more about Qutenza.

... Qutenza

We are dedicated to creating a better future for our patients, Read the package leaflet information to find out more about Ralvo.

... Ralvo

We are dedicated to creating a better future for our patients, read the package leaflet information to find out more about Tramacet.

... Tramacet

We are dedicated to creating a better future for our patients, read the package leaflet information to find out more about Versatis.

... Versatis

We are dedicated to creating a better future for our patients, read the package leaflet information to find out more about Vimovo .

... Vimovo

We are dedicated to creating a better future for our patients, read the package leaflet information to find out more about Zydol.

... Zydol

We are dedicated to creating a better future for our patients, read the package leaflet information to find out more about Zomig.

... Zomig

Patients’ needs are at the heart of everything we do; using our passion for science, we develop long-lasting solutions that directly address these needs. Read the package leaflet information to find out more about our products.

... Reporting Safety and Quality Related complaints

Taking action against pain

We are dedicated to creating a better future for our patients, so getting involved with diverse initiatives that support this goal is vital.

CHANGE PAIN

CHANGE PAIN is an international, non-promotional educational initiative introduced by Grünenthal across 12 European countries. It is specifically for healthcare professionals with an interest in pain management and aims to increase knowledge to advance the management of patients suffering from acute and chronic pain. CHANGE PAIN was launched in the UK over 8 years ago and currently has more than 7000 members. It is primarily web-based and hosts a range of CPD-accredited interactive modules, learning resources, tools, an image library etc. Many international and national experts, clinical and non-clinical, have either presented CHANGE PAIN and/or have contributed to the educational content.

... Visit Change Pain website

EFIC-Grünenthal Grant (E-G-G)

Biennial grants from Grünenthal offer €200,000 every two years for the E-G-G. E-G-G is intended to support early-career scientists to carry out innovative clinical pain research in any member country of the European Pain Federation EFIC®. Individual research grants are worth up to € 40,000 per project for a duration of up to two years. Research grants are intended for clinical and human experimental pain research, including innovative educational initiatives aimed at improving diagnosis and treatment of pain. The decision on awarding grants is made independently by a sub-group of the Working group for grants and prizes of the EFIC®.

... Check out the latest E-G-G research projects

M-N/A-UK-09-23-0006- September 2023